Mission Bio
PrivateLast Round
Early Funding
Aug 5, 2025
Total Funding Raised
$112M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mission Bio is a life sciences company that develops and commercializes the Tapestri Platform, a precision genomics tool for high-throughput single-cell multi-omics analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mission Bio Comparables
Compare Mission Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Singleron Biotechnologies | 90% | |
| BioSkryb Genomics | 86% | |
| Atrandi Biosciences | 80% |
Mission Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Aug 5, 2025 | ||||
| Series C | Aug 13, 2020 | ||||
| Grant | Oct 10, 2019 | ||||
| Series B | Dec 13, 2018 | ||||
| Series A | Oct 17, 2017 | ||||
Seed | Feb 6, 2017 |
Key People
Founding team and executive leadership
Mission Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Soleus Capital | Series C |
| Cota Capital | Early Funding, Series B, Series C |
| National Cancer Institute | Grant |
| StartX | Series A |
| Keiretsu Forum | Series A, Seed |
| Ally Bridge Group | Early Funding |
| Agilent Ventures | Early Funding, Series B, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 45% MoM, reaching 12.8K.
- Nov 20, 2025
New product announced at the ASH 2025 conference.
Mission Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Mission Bio's valuation, stock price, and market status.
Is Mission Bio a public or private company?
Mission Bio is a private company.
What is the current stock price of Mission Bio?
Mission Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Mission Bio worth (valuation)?
Valuation information for Mission Bio is not publicly available.
Can I buy Mission Bio stock?
Mission Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Mission Bio's last funding round?
Mission Bio's most recent funding round was VC Round on August 5, 2025.
Who are the main investors in Mission Bio?
Key investors in Mission Bio include Ally Bridge Group, Life Science Angels, Mayfield Fund.
Will Mission Bio IPO soon?
No public IPO plans have been announced for Mission Bio.
How can I track Mission Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mission Bio's secondary market activity and sign up for updates.